| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
59,320,000 |
| Market
Cap: |
3.19(B) |
| Last
Volume: |
1,238,329 |
Avg
Vol: |
537,066 |
| 52
Week Range: |
$52.23 - $93.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1070 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
51,087 |
| Total Sell Value |
$0 |
$0 |
$0 |
$4,585,191 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
17 |
| End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johnson Lloyd Emerson |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
12,933 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
24,981 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
19,373 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
23,357 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
7,126 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
16,872 |
|
- |
|
| Bryant Diane M |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
7,126 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2025-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,693 |
15,394 |
|
- |
|
| Maunsell Farris Maryanne |
VP, Chief Accounting Officer |
• • – |
2025-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,662 |
4,478 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2025-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,195 |
29,163 |
|
- |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2025-05-30 |
4 |
D |
$69.38 |
$406,844 |
D/D |
(5,864) |
28,292 |
|
- |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2025-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
12,221 |
34,156 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2025-05-30 |
4 |
D |
$69.38 |
$518,199 |
D/D |
(7,469) |
42,252 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2025-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,554 |
49,721 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2025-05-30 |
4 |
D |
$69.38 |
$1,820,115 |
D/D |
(26,234) |
375,544 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2025-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
66,666 |
401,778 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2025-05-30 |
4 |
D |
$69.38 |
$158,395 |
D/D |
(2,283) |
25,968 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2025-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,777 |
28,251 |
|
- |
|
| Galvin Roy |
EVP, Chief Commercial Officer |
• • – |
2025-05-16 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,689 |
12,932 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2025-05-16 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,755 |
35,233 |
|
- |
|
| Maunsell Farris Maryanne |
VP, Chief Accounting Officer |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
800 |
1,816 |
|
- |
|
| Darecca James |
EVP, Chief Financial Officer |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,111 |
21,935 |
|
- |
|
| Chan Frank |
EVP, Chief Operating Officer |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,689 |
5,689 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
21,405 |
335,112 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,689 |
34,167 |
|
- |
|
577 Records found
|
|
Page 1 of 24 |
|
|
1.41 (2.69%) 
